133 related articles for article (PubMed ID: 12010776)
21. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice.
Kimball ES; Wallace NH; Schneider CR; D'Andrea MR; Hornby PJ
Neurogastroenterol Motil; 2004 Dec; 16(6):811-8. PubMed ID: 15601431
[TBL] [Abstract][Full Text] [Related]
22. Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons.
Tang HB; Li YS; Arihiro K; Nakata Y
Mol Pain; 2007 Dec; 3():42. PubMed ID: 18157919
[TBL] [Abstract][Full Text] [Related]
23. Spatial and temporal expression of tachykinins and NK1- and NK2-receptor gene during TNB induced colitis in rats.
Evangelista S; Tramontana M; Maggi CA
Neuropeptides; 2008; 42(5-6):663-70. PubMed ID: 18715640
[TBL] [Abstract][Full Text] [Related]
24. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
25. Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblasts.
Rameshwar P; Poddar A; Zhu G; Gascón P
J Immunol; 1997 Apr; 158(7):3417-24. PubMed ID: 9120302
[TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
Hyun E; Andrade-Gordon P; Steinhoff M; Vergnolle N
Gut; 2008 Sep; 57(9):1222-9. PubMed ID: 18460552
[TBL] [Abstract][Full Text] [Related]
27. Substance P excites globus pallidus neurons in vivo.
Cui QL; Yung WH; Xue Y; Chen L
Eur J Neurosci; 2007 Oct; 26(7):1853-61. PubMed ID: 17868370
[TBL] [Abstract][Full Text] [Related]
28. Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice.
Pandurangan AK; Mohebali N; Norhaizan ME; Looi CY
Drug Des Devel Ther; 2015; 9():3923-34. PubMed ID: 26251571
[TBL] [Abstract][Full Text] [Related]
29. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
30. M3 muscarinic receptor-deficient mice retain bethanechol-mediated intestinal ion transport and are more sensitive to colitis.
Hirota CL; McKay DM
Can J Physiol Pharmacol; 2006 Nov; 84(11):1153-61. PubMed ID: 17218980
[TBL] [Abstract][Full Text] [Related]
31. Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFalpha in the cutaneous microvasculature.
Costa SK; Yshii LM; Poston RN; Muscará MN; Brain SD
J Neuroimmunol; 2006 Feb; 171(1-2):99-109. PubMed ID: 16269189
[TBL] [Abstract][Full Text] [Related]
32. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
[TBL] [Abstract][Full Text] [Related]
33. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
35. Immunology: what is the proximal cause of inflammation?
Walport MJ; Taylor PR
Curr Biol; 1997 Jan; 7(1):R41-3. PubMed ID: 9072169
[TBL] [Abstract][Full Text] [Related]
36. Neurokinin-induced generation of interleukin-1 in a macrophage cell line.
Kimball ES; Persico FJ; Vaught JL
Ann N Y Acad Sci; 1988; 540():688-90. PubMed ID: 2462840
[No Abstract] [Full Text] [Related]
37. Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer.
Coveñas R; Muñoz M
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884599
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into the activation of neurokinin 2 receptor by neurokinin A.
Sun W; Yuan Q; Zhang H; Yang F; Ling S; Luo Y; Lv P; Eric Xu H; Tian C; Yin W; Shi P
Cell Discov; 2022 Jul; 8(1):72. PubMed ID: 35882833
[No Abstract] [Full Text] [Related]
39. Regulation of Carcinogenesis by Sensory Neurons and Neuromediators.
Erin N; Shurin GV; Baraldi JH; Shurin MR
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565462
[TBL] [Abstract][Full Text] [Related]
40. Neurokinin receptors and their implications in various autoimmune diseases.
Mishra A; Lal G
Curr Res Immunol; 2021; 2():66-78. PubMed ID: 35492389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
